1. Knowledge mapping and current trends of m6A methylation in the field of cancer
    Chunming Zhu et al, 2024, Heliyon CrossRef
  2. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma
    Min Deng et al, 2021, Mutagenesis CrossRef
  3. Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
    Chen Xue et al, 2022, Signal Transduction and Targeted Therapy CrossRef
  4. RNA m6A methylation regulators in endometrial cancer (Review)
    Siyi Shen et al, 2022, International Journal of Oncology CrossRef
  5. Role of m6A modification in immune microenvironment of digestive system tumors
    Chao Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  6. Effects of m6A RNA methylation regulators on endometrial cancer
    Yanli Zhang et al, 2021, Journal of Clinical Laboratory Analysis CrossRef
  7. Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
    Xiu-kun Chai et al, 2021, Frontiers in Genetics CrossRef
  8. Insights into N6-methyladenosine and programmed cell death in cancer
    Li Liu et al, 2022, Molecular Cancer CrossRef
  9. The role of RNA m6A methylation in lipid metabolism
    Yuting Wang et al, 2022, Frontiers in Endocrinology CrossRef
  10. Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS
    Takahiro Kogaki et al, 2021, Journal of Pharmaceutical and Biomedical Analysis CrossRef
  11. ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner
    Luyao Li et al, 2021, Ecotoxicology and Environmental Safety CrossRef
  12. m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis
    Fang-Yi Yao et al, 2021, Frontiers in Oncology CrossRef
  13. Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer
    Cecilia Vittori et al, 2022, Cancer Cell International CrossRef
  14. Sevoflurane inhibits oral squamous carcinoma progression by modulating the circ_0000857/miR‐145‐5p axis
    Yingbo Feng et al, 2024, Chemical Biology & Drug Design CrossRef
  15. An epigenetic ‘extreme makeover’: the methylation of flaviviral RNA (and beyond)
    Alessia Ruggieri et al, 2021, RNA Biology CrossRef
  16. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer
    Jian Ma et al, 2021, Aging CrossRef
  17. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma
    Bing-fan Xie et al, 2022, Computational Intelligence and Neuroscience CrossRef
  18. Highly Selective Electrochemical Detection of 5-Formyluracil Relying on (2-Benzimidazolyl) Acetonitrile Labeling
    Jing Tang et al, 2021, Analytical Chemistry CrossRef
  19. RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy
    Peng Song et al, 2022, Journal of Bioinformatics and Computational Biology CrossRef
  20. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer
    Xiaoqin Lu et al, 2022, Journal of Translational Medicine CrossRef
  21. m6A Topological Transition Coupled to Developmental Regulation of Gene Expression During Mammalian Tissue Development
    Shanshan Li et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  22. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms
    Peng He et al, 2024, Molecular and Cellular Biochemistry CrossRef